(Q67900332)

English

Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration

scientific article published on 01 February 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

H. Ujike

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829015

4 December 2022

K. Akiyama

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829015

4 December 2022

H. Nishikawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829015

4 December 2022

T. Onoue

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829015

4 December 2022

S. Otsuki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829015

4 December 2022

language of work or name

0 references

publication date

1 February 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:000689939190503N?httpAccept=text/xml

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

https://api.elsevier.com/content/article/PII:000689939190503N?httpAccept=text/plain

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

540

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

159-163

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine--an in vivo dialysis study in freely moving rats.

1

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Topography of substantia nigra innervation by D1 receptor-containing striatal neurons

2

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography.

3

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Turning behaviour following nigral injections of dopamine agonists and glycine.

4

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

6

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study

7

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Dendritic release of dopamine in the substantia nigra

8

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

9

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Substance P in the substantia nigra

10

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

The striatum and substantia nigra: A commentary on their relationships

11

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

12

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours

13

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Role of nigral dopamine in amphetamine-induced locomotor activity.

16

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

20

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

21

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Two distinct strio-nigral substance P pathways in the rat: An experimental immunohistochemical study

22

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Comparison of the substance P- and dynorphin-containing projections to the substantia nigra: a radioimmunocytochemical and biochemical study

23

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment

24

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Amphetamine-induced release of dopamine from the substantia nigra in vitro

25

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamine

27

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine

28

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.

31

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy

33

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors

35

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine

36

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum

38

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Effects of acute and long-term treatment with methamphetamine on substance P concentration and receptor numbers in the rat brain

39

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization

40

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390

41

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway

42

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses

43

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway

44

1 reference

10.1016/0006-8993(91)90503-N

https://api.crossref.org/works/10.1016/0006-8993(91)90503-N

4 December 2022

Identifiers

10.1016/0006-8993(91)90503-N

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1829015%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67900332&oldid=1814502574"